Acquisition by Romano Gary of 184380 shares of Alector subject to Rule 16b-3
ALEC Stock | USD 1.72 0.05 2.82% |
About 56% of Alector's investor base is looking to short. The analysis of the overall investor sentiment regarding Alector suggests that many traders are alarmed. The current market sentiment, together with Alector's historical and current headlines, can help investors time the market. In addition, many technical investors use Alector stock news signals to limit their universe of possible portfolio assets.
Alector |
Filed transaction by Alector Officer: Chief Medical Officer. Grant, award or other acquisition pursuant to Rule 16b-3(d)
Read at macroaxis.com
Cash Flow Correlation
Alector's cash-flow correlation analysis can be used to evaluate the unsystematic risk during the given period. It also helps investors identify the Alector's relationships between the major components of the statement of changes in financial position and other commonly used cash-related accounts. When such correlations are discovered, they may help managers and analysts to enhance performance or determine appealing investment opportunities.Click cells to compare fundamentals
Alector Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Alector can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Alector Fundamental Analysis
We analyze Alector's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Alector using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Alector based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Return On Asset
Return On Asset Comparative Analysis
Alector is currently under evaluation in return on asset category among its peers. Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Alector Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Alector stock to make a market-neutral strategy. Peer analysis of Alector could also be used in its relative valuation, which is a method of valuing Alector by comparing valuation metrics with similar companies.
Peers
Alector Related Equities
STOK | Stoke Therapeutics | 2.18 | ||||
CABA | Cabaletta Bio | 1.02 | ||||
GLUE | Monte Rosa | 0.17 | ||||
LRMR | Larimar Therapeutics | 0.68 | ||||
RVMD | Revolution Medicines | 2.03 | ||||
PASG | Passage Bio | 3.77 | ||||
BDTX | Black Diamond | 6.45 |
Complementary Tools for Alector Stock analysis
When running Alector's price analysis, check to measure Alector's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Alector is operating at the current time. Most of Alector's value examination focuses on studying past and present price action to predict the probability of Alector's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Alector's price. Additionally, you may evaluate how the addition of Alector to your portfolios can decrease your overall portfolio volatility.
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume |